Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
11.83
-0.25 (-2.07%)
Jul 11, 2025, 9:58 AM - Market open
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $1.80 billion as of July 11, 2025. Its market cap has increased by 270.67% in one year.
Market Cap
1.80B
Enterprise Value
1.82B
1-Year Change
270.67%
Ranking
Category
Stock Price
$11.83
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $1.80B, a decrease of -62.36%. That is a compound annual growth rate of -14.93%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.79B |
| Johnson & Johnson | 379.41B |
| AbbVie | 344.45B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.70B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 223.49B |